Brawn Biotech Limited (BOM:530207)
India flag India · Delayed Price · Currency is INR
19.00
+0.47 (2.54%)
At close: Jun 17, 2026

Brawn Biotech Balance Sheet

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
2.811.993.974.392.25
Cash & Short-Term Investments
2.811.993.974.392.25
Cash Growth
40.68%-49.80%-9.46%95.36%-43.31%
Accounts Receivable
35.4834.1338.8353.1528.1
Other Receivables
-0.140.920.99.27
Receivables
35.6134.4739.9654.2137.49
Inventory
100.62104.6760.1747.9147.24
Prepaid Expenses
-1.842.252.573.25
Other Current Assets
32.1632.0325.0524.9231.64
Total Current Assets
171.2175131.4133.99121.87
Property, Plant & Equipment
3.654.63.333.723.86
Long-Term Accounts Receivable
19.1920.146.595.995.88
Long-Term Deferred Tax Assets
14.545.154.571.596.24
Other Long-Term Assets
--0--
Total Assets
208.57204.89145.89145.3137.85
Accounts Payable
144.0982.3856.7564.6940.52
Accrued Expenses
-2.83.54.694.93
Current Income Taxes Payable
-0.260.251.517.22
Other Current Liabilities
7.627.834.589.5810.55
Total Current Liabilities
151.793.2765.0880.4763.21
Pension & Post-Retirement Benefits
-0.81.030.830.64
Other Long-Term Liabilities
13.4877.229.130.911.79
Total Liabilities
165.18171.2795.2482.2165.64
Common Stock
3030303030
Additional Paid-In Capital
-15.215.215.215.2
Retained Earnings
--11.735.317.7426.85
Comprehensive Income & Other
13.390.150.150.150.15
Shareholders' Equity
43.3933.6250.6563.0972.2
Total Liabilities & Equity
208.57204.89145.89145.3137.85
Net Cash (Debt)
2.811.993.974.392.25
Net Cash Growth
40.68%-49.80%-9.46%95.36%-43.31%
Net Cash Per Share
0.970.661.321.460.75
Filing Date Shares Outstanding
2.993333
Total Common Shares Outstanding
2.993333
Working Capital
19.581.7466.3253.5358.66
Book Value Per Share
14.5011.2116.8821.0324.07
Tangible Book Value
43.3933.6250.6563.0972.2
Tangible Book Value Per Share
14.5011.2116.8821.0324.07
Machinery
-10.247.837.716.75